RAPT Therapeutics News

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 5 00:00 ET

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 21, 2023 10:46 ET

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 28, 2023 11:26 ET

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 3, 2023 16:23 ET

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 18, 2023 10:42 ET

RAPT Therapeutics | EFFECT: Others

Aug 18, 2023 00:15 ET

RAPT Therapeutics | 424B5: Prospectus

Aug 17, 2023 17:42 ET

RAPT Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 19, 2023 10:43 ET

RAPT Therapeutics | 424B5: Prospectus

Nov 18, 2022 16:52 ET

RAPT Therapeutics | 424B5: Prospectus

Nov 17, 2022 17:14 ET

RAPT Therapeutics | EFFECT: Others

Jun 30, 2022 00:15 ET

RAPT Therapeutics | 424B3: Prospectus

Jun 29, 2022 16:18 ET

RAPT Therapeutics | 424B5: Prospectus

Jun 16, 2021 16:32 ET

RAPT Therapeutics | 424B5: Prospectus

Jun 14, 2021 16:06 ET

RAPT Therapeutics | EFFECT: Others

Nov 17, 2020 00:15 ET

RAPT Therapeutics | 424B4: Prospectus

Feb 7, 2020 16:18 ET

RAPT Therapeutics | EFFECT: Others

Feb 7, 2020 00:15 ET

RAPT Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 6, 2020 21:15 ET

RAPT Therapeutics | 424B4: Prospectus

Oct 31, 2019 21:26 ET

RAPT Therapeutics | EFFECT: Others

Oct 31, 2019 00:15 ET